News

December 14, 2018December 14, 2018

MS Patients Report Beneficial Effects of Cannabis With Few Side Effects, Survey Shows

News

Many multiple sclerosis (MS) patients report that cannabis has beneficial effects on their symptoms with minimal side effects, according to a survey that also showed that ... Read more

December 14, 2018December 14, 2018

Researchers Develop Smartphone-connected Device to Treat MS, Brain Disorders Remotely

News

Researchers at the Ural Federal University (UrFU) in Russia have developed a neuro-electrostimulation system that has the potential to treat different types of brain disorders, including ... Read more

December 13, 2018December 13, 2018

Patients with Stable Disease Who Switch to Another Interferon Therapy at Greater Risk of Flares, Study Reports

News

Multiple sclerosis (MS) patients who have been relapse-free while using an interferon-beta (IFN-β) therapy but switch to another IFN-β are significantly more like to start experiencing flares than patients ... Read more

December 13, 2018December 13, 2018

Lipoic Acid Supplements May Help to Delay Decline in Walking Speed in SPMS Patients, Study Says

News

Lipoic acid (LA), an over-the-counter antioxidant supplement, helps to mildly delay a decline in walking speed in secondary progressive multiple sclerosis (SPMS) patients, particularly those with lesser disability, ... Read more

December 12, 2018December 12, 2018

GB Sciences, LSU Partner on Cannabinoid Research and Development Project for MS, Other Diseases

News

As debate continues about the effects of medical marijuana on multiple sclerosis (MS) and other diseases, cannabis company GB Sciences and Louisiana State University (LSU) have agreed on a ... Read more

December 12, 2018December 12, 2018

Ocrevus Now Available Through NHS Scotland to Treat RRMS

News

Ocrevus (ocrelizumab, by Genentech) is now available through the National Health System (NHS) of Scotland to treat patients with relapsing-remitting multiple sclerosis (RRMS). The decision by ... Read more

December 11, 2018December 11, 2018

Glatect Added to Public Drug Plan in British Columbia as Sole RRMS Treatment of Its Type

News

Pendopharm’s Glatect (glatiramer acetate) — a treatment for patients with relapsing-remitting multiple sclerosis (RRMS) — has been added to the public drug plan in the Canadian ... Read more

December 11, 2018December 11, 2018

WUSTL Team Receives $6.3 Million Grant to Develop PET Scan Tracers

News

The Washington University School of Medicine in St. Louis (WUSTL) will create a new research center to investigate and advance the development of tracers for positron emission ... Read more

December 10, 2018December 10, 2018

Microglia Cells Diverse with Distinct Subtypes and Certain Ones May Contribute to Inflammation, Study Finds

Alexa, News

Microglia, the resident immune cells of the brain, were seen to change throughout the lifespan of mice in a study — and to be diverse, with ... Read more

December 10, 2018December 10, 2018

Research Team Chosen to Lead to Novel Research Project in Canada into MS Progression

News

With a renowned researcher and her team chosen to lead it, work can now begin on the first project of its kind in Canada designed to ... Read more

December 7, 2018December 7, 2018

Tysabri Seen as Superior to IFN-β in Preventing Relapses, Easing Disability in Small Study

News

Tysabri (natalizumab) was found to be superior to interferon beta (IFN-β) in a small, 12-month study with relapsing-remitting multiple sclerosis (RRMS) patients, significantly decreasing their disability ... Read more

December 7, 2018December 7, 2018

Treating MS with Holistic Behaviors and Strategies: A Nutritionist’s View

News

When I first met Stephanie in March, she was like any healthy 28-year-old coming in to see me for a nutrition consult. Her positive attitude and ... Read more

December 7, 2018December 7, 2018

Aubagio Becomes 1st Once-daily Oral DMT for Relapsing MS Patients in India

News

Aubagio (teriflunomide) has become the first once-a-day, oral disease-modifying therapy (DMT) for multiple sclerosis (MS) to be approved for use in India. Sanofi Genzyme’s therapy is indicated for ... Read more

December 6, 2018December 6, 2018

Fat Spheres Can Deliver DNA into Cells of Central Nervous System, Hold Therapeutic Potential

News

Non-viral vehicles, called niosomes, can deliver DNA to glial cells in the central nervous system, a new study shows. The findings open new avenues for gene ... Read more

December 6, 2018December 6, 2018

Use of Hospital Palliative Care by MS Patients in US Rose 30-fold Between 2005-14, Study Finds

News

Palliative care in a hospital setting rose 30 fold among multiple sclerosis (MS) patients in the U.S. from 2005 to 2014, and was associated with longer hospital ... Read more

December 5, 2018December 7, 2018

Aspirin Suppresses MS Symptoms by Preventing Loss of Regulatory T-cells, Mouse Study Shows

News

Aspirin, administered orally at low doses, was sufficient to suppress multiple sclerosis (MS) symptoms in a mouse model of relapsing-remitting MS (RRMS) and chronic MS, a ... Read more

December 5, 2018December 11, 2018

Lemtrada Linked to Bleeding in Lungs in Case Report, 1 of 5 MS Cases Worldwide, Study Says

News

A potentially life-threatening case of bleeding in the lungs has been reported and attributed to treatment with Lemtrada (alemtuzumab) by a woman with relapsing-remitting multiple sclerosis. Her medical team ... Read more

December 4, 2018December 13, 2018

RRMS Patients on Rebif Show High Treatment Adherence and Fewer Relapses in Real-World Study

News

Patients with relapsing-remitting multiple sclerosis (RRMS) on Rebif (interferon beta 1-a), using the RebiSmart autoinjector, have high treatment adherence, despite seasonal weather or temperature fluctuations, as well ... Read more

December 4, 2018December 7, 2018

Small Molecule Linked to Cells That Control Myelin Production and Repair in Study

News

The formation of new myelin sheaths by oligodendrocytes is impaired in the absence of a small molecule, called Vav3, that oversees pathways regulating the shape of ... Read more

December 3, 2018December 11, 2018

Mumford & Sons Bassist Helps UK MS Society Tackle Patient Loneliness with New Exhibit

News

A musician, a member of Parliament, and the Multiple Sclerosis Society in the United Kingdom have joined forces to increase awareness on the social isolation that ... Read more

December 3, 2018December 11, 2018

Lemtrada’s Use Carries Rare But Serious Risk of Stroke and Artery Tears, FDA Warns

News

The U.S. Food and Drug Administration (FDA) has issued a safety alert, warning about a rare but life-threatening risk of stroke and artery rupture in patients with ... Read more

November 30, 2018December 13, 2018

Gilenya Now Approved in Europe to Treat Children, Adolescents with RRMS

News

Gilenya (fingolimod) was approved by the European Commission as a treatment for children and adolescents, ages 10 to 17, with relapsing-remitting multiple sclerosis (RRMS), Novartis announced. ... Read more

November 30, 2018December 5, 2018

CDC Launching National Neurological Conditions Surveillance System to Study MS

News

The U.S. Congress is supporting with $5 million the National Neurological Conditions Surveillance System (NNCSS), an initiative to be launched by the Centers for Disease Control ... Read more

November 29, 2018December 4, 2018

Adult Oligodendrocytes May Replenish Myelin Production in MS, Study Suggests

News

Mature, adult oligodendrocytes can reacquire their ability to produce myelin to replace the ones lost in diseases like multiple sclerosis (MS) without undergoing a stem cell-like ... Read more

November 29, 2018November 29, 2018

Stem Cells With Unusual Metabolism May Be Therapeutic Approach to Fight Inflammatory Diseases Like MS, Study Suggests

News

Human mesenchymal stem cells (hMSCs), the type of stem cells present in many tissues of adults, may be manipulated to fight inflammation and used as a ... Read more

November 28, 2018December 4, 2018

Artificial Intelligence May Help Reduce Dosage of Gadolinium in MRIs, Researchers Suggest

News

Artificial intelligence can help reduce the amount of gadolinium used as a contrast agent in MRI (magnetic resonance imaging) scans, preventing the agent’s potential toxicity when ... Read more

November 28, 2018December 4, 2018

High Lipid Levels Associated with Increased Disability, Inflammation in RRMS Patients, Study Shows

News

High levels of certain lipids, or fat, in the blood are linked to increased disability scores and high levels of pro-inflammatory markers in relapsing-remitting multiple sclerosis (RRMS) ... Read more

November 27, 2018November 29, 2018

Lifestyle Factors Tied to MS-related Depression, Large Study Finds

News

Changeable lifestyle factors influence the risk and severity of depression associated with multiple sclerosis (MS), a study based on a large group of patients shows. According ... Read more

November 27, 2018December 4, 2018

Homotaurine Compound May Be New Class of Treatment for MS, Mouse Study Suggests

News

Homotaurine, a compound proven safe for humans in long-term clinical trials, has eased autoimmune responses, brain inflammation, and multiple sclerosis-like symptoms in a mouse model of ... Read more

November 26, 2018November 29, 2018

FDA Warns of Rare Risk of Severe Worsening in MS Disability After Stopping Gilenya Use

News

The U.S. Food and Drug Administration (FDA) has issued a safety alert, warning that people with relapsing multiple sclerosis (MS) who stop using Gilenya (fingolimod) may experience disease worsening beyond ... Read more

November 26, 2018December 4, 2018

Gilenya-induced Changes in Heart Rate May Predict Degree of Drop in Lymphocytes, Study Reports

News

Assessing changes in a person’s heart rate can help to predict the degree to which lymphocyte numbers will decrease in relapsing-remitting multiple sclerosis (RRMS) patients using Gilenya ... Read more

November 21, 2018November 21, 2018

Phase 1 Trial of ATA190 Cell Therapy Shows Promise in Treating Progressive MS

News

Atara Biotherapeutics’ investigational ATA190, a cell therapy that wipes out immune B-cells infected with the Epstein-Barr virus (EBV), led to neurological improvements and reduced symptoms in ... Read more

November 21, 2018November 21, 2018

Phase 2 Trial of NurOwn Stem Cell Therapy in Progressive MS Planned for US, BrainStorm Announces

News

BrainStorm Cell Therapeutics is planning to launch a Phase 2 clinical trial in the United States to evaluate the safety and activity of its lead cell ... Read more

November 20, 2018November 28, 2018

FDA Approves Generic Version of Aubagio to Treat Relapsing MS, Glenmark Pharma Says

News

The U.S. Food and Drug Administration (FDA) has approved a generic version of  Aubagio (teriflunomide) tablets at the 7 mg and 14 mg  doses marketed by Sanofi, ... Read more

November 20, 2018November 28, 2018

RRMS Diagnosed Most Often in Younger Women and PPMS in Older Men, European Study Reports

News

Women with multiple sclerosis are being diagnosed at younger ages and in greater numbers than men, except for those with primary progressive disease (PPMS), where men 50 ... Read more

November 19, 2018November 19, 2018

Accelerated Cure Project, National MS Society Pair to Advance Research, Patient Input

News

Hoping to expedite multiple sclerosis (MS) research and boost patient participation, the Accelerated Cure Project (ACP) for Multiple Sclerosis is teaming with the National Multiple Sclerosis ... Read more

November 19, 2018November 19, 2018

MS Therapy Fampyra Again Not Recommended for Use in Scottish National Health System

News

The Scottish Medicines Consortium (SMC) issued a negative recommendation on the use of Fampyra (fampridine; marketed as Ampyra in the U.S.) in the National Health System ... Read more

November 16, 2018November 28, 2018

Celgene and Lyfebulb Partner on ‘Innovation Challenge’ for Entrepreneurs Affected by MS

News

Lyfebulb announced that it has joined with Celgene in launching an innovation challenge for entrepreneurs with or impacted by multiple sclerosis (MS) to develop user-driven solutions that might ... Read more

November 16, 2018November 16, 2018

Unemployment and Under-employment Linked to Poorer Cognitive Abilities in UK Study

News

Multiple sclerosis patients of working age who are unemployed or on a reduced work schedule are likely to show considerable cognitive impairment on tests, especially those measuring ... Read more

November 15, 2018November 20, 2018

MS-specific Lineage of Oligodendrocytes May Provide New Hints on MS Development

News

The cells that produce myelin in the brain and spinal cord, called oligodendrocytes, may play an active role in the onset or progression of multiple sclerosis ... Read more